A population-based risk factor scoring will decrease unnecessary testing for the diagnosis of gestational diabetes mellitus
Article first published online: 10 MAY 2004
Acta Obstetricia et Gynecologica Scandinavica
Volume 83, Issue 6, pages 524–530, June 2004
How to Cite
Caliskan, E., Kayikcioglu, F., Öztürk, N., Koc, S. and Haberal, A. (2004), A population-based risk factor scoring will decrease unnecessary testing for the diagnosis of gestational diabetes mellitus. Acta Obstetricia et Gynecologica Scandinavica, 83: 524–530. doi: 10.1111/j.0001-6349.2004.00389.x
- Issue published online: 10 MAY 2004
- Article first published online: 10 MAY 2004
- Submitted 21 February, 2003 Accepted 20 August, 2003
- gestational diabetes mellitus;
- risk factors;
- selective screening
Background. To determine the effectiveness of a population-based risk factor scoring to decrease unnecessary testing for the diagnosis of gestational diabetes mellitus (GDM).
Methods. We formed a risk factor scoring over five, which questions maternal age, body mass index and first-degree relatives with a diagnosis of diabetes mellitus, a prior macrosomic fetus and adverse outcome during the previous pregnancies. All participants underwent a 50-g glucose challenge test (GCT) followed by a 100-g oral glucose tolerence test (OGTT). We opened the 50-g GCT envelope if the participant had a risk score ≥ 1 and opened the 100-g OGTT envelope if the 50-g GCT value was ≥ 7.2 mmol/l. After all patients delivered we also built other strategies and tested their detection rates.
Results. Fourteen patients (3.3%) were diagnosed as having gestational diabetes mellitus via a 100-g OGTT. None of the patients with a score of zero had gestational diabetes mellitus. Logistic regression analysis revealed that an increase in the score by one caused a three times increase in gestational diabetes mellitus risk (OR = 3, CI = 1.9–5). Compared with the universal screening, our strategy to screen if the risk score was ≥ 1, followed by a 50-g GCT with a 7.2-mmol/l cut-off value, decreased the number of women to be screened by 30% and diagnosed all cases with GDM. Screening the patients with a score ≥ 2 would have decreased the number of women to be screened by 63%, still diagnosing 85% of cases with GDM. Also, risk factor-based screening strategies cause a 50% and 53% reduction in the number of OGTT applied, respectively.
Conclusion. A well integrated, population-based scoring will decrease the number of unnecessary testing but still diagnose 85–100% of GDM cases.